Literature DB >> 27177665

Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.

Minh-Trang Thi Phan1, Seung-Hwan Lee2, Sang-Ki Kim3, Duck Cho4.   

Abstract

Natural killer (NK) cells can be expanded upon activation by proliferative cytokines (such as IL-2 and IL-15). The NK cell expansion can be greatly enhanced by proteins from feeder cells such as tumor cell lines or PBMCs. Therefore, coculture systems of irradiated feeder cells and NK cells in media containing IL-2 and IL-15 have been developed to generate large numbers of NK cells, although NK cell expansion protocol using anti-CD3 antibody (OKT-3) without feeder cells has also been developed. Commonly used feeder cell lines are RPMI8866, Epstein-Barr lymphoblastoid cell line (EBV-LCL), and K562. Stimulation with NK-sensitive K562 cells is known to augment NK cell proliferation to IL-2, IL-15, and IL-21 in combination.Recently, remarkable NK cell-expansion rates are achieved when genetically engineered (GE) feeder cells are used. Dr. Dario Campana's group found that membrane-bound IL-15 and 4-1BBL, coexpressed by K562 cells, acted synergistically to augment K562-specific NK stimulatory capacity, resulting in vigorous expansion of peripheral blood CD56(+) CD3(-) NK cells without concomitant growth of T lymphocytes. Here, we describe an in vitro expansion method of human NK cells among PBMCs by coculturing with GE_K562 cells.

Entities:  

Keywords:  Expansion; Feeder cells; K562; Natural killer cell

Mesh:

Substances:

Year:  2016        PMID: 27177665     DOI: 10.1007/978-1-4939-3684-7_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Cytomegalovirus: an unlikely ally in the fight against blood cancers?

Authors:  A B Bigley; F L Baker; R J Simpson
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

2.  Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo-Expanded Autologous NK Cells.

Authors:  Yufeng Wang; Yibo Zhang; Tiffany Hughes; Jianying Zhang; Michael A Caligiuri; Don M Benson; Jianhua Yu
Journal:  Clin Cancer Res       Date:  2018-04-17       Impact factor: 12.531

Review 3.  Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review).

Authors:  Xiaobo Peng; Ling Chen; Longpei Chen; Bin Wang; Yiran Wang; Xianbao Zhan
Journal:  Exp Ther Med       Date:  2021-02-10       Impact factor: 2.447

4.  Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand.

Authors:  Se-Jeong Oh; Jung-In Yang; Ok Kim; Eun-Jung Ahn; Woo Dae Kang; Jae-Hyuk Lee; Kyung-Sub Moon; Kyung-Hwa Lee; Duck Cho
Journal:  Cancer Cell Int       Date:  2017-02-10       Impact factor: 5.722

5.  Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.

Authors:  SoonHo Kweon; Minh-Trang Thi Phan; Sejong Chun; HongBi Yu; Jinho Kim; Seokho Kim; Jaemin Lee; Alaa Kassim Ali; Seung-Hwan Lee; Sang-Ki Kim; Junsang Doh; Duck Cho
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

Review 6.  Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.

Authors:  Margaret G Lamb; Hemalatha G Rangarajan; Brian P Tullius; Dean A Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-25       Impact factor: 6.832

7.  Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.

Authors:  Shin Yi Tang; Shijun Zha; Zhicheng Du; Jieming Zeng; Detu Zhu; Yumei Luo; Shu Wang
Journal:  Stem Cell Res Ther       Date:  2021-11-21       Impact factor: 6.832

8.  The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.

Authors:  Amanda B Macedo; Callie Levinger; Bryan N Nguyen; Jonathan Richard; Mamta Gupta; Conrad Russell Y Cruz; Andrés Finzi; Katherine B Chiappinelli; Keith A Crandall; Alberto Bosque
Journal:  J Virol       Date:  2022-07-14       Impact factor: 6.549

9.  Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.

Authors:  Jaya Lakshmi Thangaraj; Minh-Trang Thi Phan; SoonHo Kweon; Jinho Kim; Jong-Min Lee; Ilwoong Hwang; Jeehun Park; Junsang Doh; Seung-Hwan Lee; Manh-Cuong Vo; Tan-Huy Chu; Ga-Young Song; Seo-Yeon Ahn; Sung-Hoon Jung; Hyeoung-Joon Kim; Duck Cho; Je-Jung Lee
Journal:  Cancer Immunol Immunother       Date:  2021-07-20       Impact factor: 6.968

Review 10.  Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells.

Authors:  Timo Burster; Fabian Gärtner; Christiane Bulach; Anuar Zhanapiya; Adrian Gihring; Uwe Knippschild
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.